Fig 1.
Flow-chart showing the national algorithm of HIV testing in the Democratic Republic of the Congo [12].
Alere Determine HIV-1/2 (Alere, Chiba-ken, Japan), VIKIA HIV1/2 (bioMérieux, Lyon, France), and Uni-Gold HIV (Trinity Biotech, Wicklow, Ireland) were used as the first, second, and third test, respectively.
Fig 2.
Flow chart showing the recruitment of study participants and their acceptability with regard to using the Exacto Test HIV Self-test (Biosynex, Strasbourg, France).
Table 1.
Characteristics of 628 adolescents living in Kisangani according to sex.
Table 2.
Acceptability of and preferences for HIV self-testing according to pre-testing and post-testing phases among 597 adolescents living in Kisangani.
Table 3.
Analytical results of the feasibility to use the finger-stick whole blood self-test (Exacto Test HIV Self-test, Biosynex) and obtain a valid result in a home-based, supervised survey among 597 adolescents living in Kisangani.
Table 4.
Bivariate and multivariate regression analysis of factors associated with the successful performance of Exacto Test HIV Self-test (Biosynex) and the correct interpretation of self-test results among the 597 study participants.